Guyana’s Environmental Protection Agency (EPA) is a vital pillar in the country’s balancing act of being an oil producer, while also adhering to strict global climate goals.  And because of this, its institutional capacity must be strengthened to monitor and...

Lebrikizumab is a novel monoclonal antibody that binds to IL-13 with high affinity and prevents its downstream signaling with high potency The NEJM manuscript reports Week 16 efficacy and safety data from ADvocate1 and ADvocate2, two identically designed Phase 3...

Restructuring of the Company’s debt postpones initiation of repayments to Q1 2025, to be repaid with positive net royalty1 flow to Poxel anticipated to start in Sumitomo Pharma’s FY20242 based on the strong growth trajectory of TWYMEEG® (Imeglimin) sales New...

– Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overall rate of adverse events continued to decrease – – Data confirm long-term efficacy and safety...

Keeping to its strategy to divest from non-core assets, ExxonMobil is mulling selling off its majority stake in Italy’s main regasification terminal - Rovigo LNG.  Also called Adriatic LNG, the terminal is owned by ExxonMobil Italiana Gas S.r.l. which holds...

With Guyana’s draft model petroleum agreements now in the public domain, it is clear that the government is seeking to encourage international oil companies (IOCs) to commit to development of commercial discoveries in a timely manner. The contract effectively...

New Phase I data confirm high immunogenicity and promising efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation Exciting preclinical data on the novel IV oncolytic virus candidate TG6050 STRASBOURG, France--(BUSINESS WIRE)--#HBV--Regulatory News: Transgene...

Noble Corporation said its 2022 revenues for the year ended December 31, 2022 amounted to US$1.4 billion, with the King of the pile being its Guyana operations at US$469 million. Guyana, therefore, accounts for a third of Noble’s 2022...

-- First and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000 to 9,000 patients in the U.S.1 -- Company expects DAYBUE to be available by the end of April, 2023 -- Rare Pediatric Disease Priority Review...

– Clinical data submitted are consistent with global data and support enfortumab vedotin as a platinum-free option in patients with locally advanced or metastatic urothelial cancer who received prior treatment with a PD-1/L1 inhibitor and platinum-based chemotherapy – TOKYO &...